Important Information - Terms and conditions
You must read and accept this important notice before you attempt to access the electronic version of the Replacement Prospectusthrough our website. The information on this page is not part of the Replacement Prospectus. If you do not understand it, please consult your professional adviser without delay.
Lodgement of Replacement Prospectus with ASIC
The Replacement Prospectus relates to a proposed offer by Atlantic Lithium Limited ACN 127 215 132 and Atlantic SaleCo Limited ACN 660 757 344 to acquire up to 22,850,000 Shares (Sale Shares) at a price of $0.58 per Sale Share.
The Replacement Prospectus is dated 29 August 2022 and has been lodged with the Australian Securities and Investments Commission (ASIC) on that date. The Replacement Prospectus replaces the original prospectus (Original Prospectus) lodged with ASIC on 15 August 2022.
Neither ASIC nor any of their respective officers, take any responsibility for the contents of the Original Prospectus or Replacement Prospectus or the merits of the investment to which the Replacement Prospectus relates.
Applications for Sale Shares
The Corporations Act 2001 (Cth) prohibits Atlantic from processing an application form for securities under the Prospectus in the seven-day period after the date of lodgement of the Original Prospectus with ASIC . ASIC extended the exposure period from 7 days to 14 days from the lodgement of the Original Prospectus (Exposure Period). The Exposure Period concludes on 29 August 2022. Applications under this Replacement Prospectus will not be processed until after the expiry of the Exposure Period. No preference will be conferred on any application received during the Exposure Period.
Please read the Replacement Prospectus for details on how to apply for Shares under the Replacement Prospectus. If the Application Form is not completed correctly it may still be treated as valid. The Directors’ decision as to whether to treat the acceptance as valid and how to construe, amend or complete the Application Form, is final.
Electronic Prospectus
Persons who access the electronic version of the Replacement Prospectus should ensure that they download and read the entire Replacement Prospectus.
The Corporations Act prohibits any person passing onto another person an application form unless it is attached to a hard copy of the Prospectus or it accompanies the complete and unaltered version of the Prospectus. Any person may obtain a hard copy of the Replacement Prospectus free of charge by contacting Atlantic. If you have received the Replacement Prospectus as an electronic Prospectus, please ensure that you have received the entire Replacement Prospectus accompanied by an application form. If you have not, please contact Atlantic so either a hard copy or a further electronic copy of the Replacement Prospectus or both can be sent to you free of charge.
No Advice
Nothing contained on this website or in the Replacement Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Replacement Prospectus does not take into account your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of Atlantic and its securities and terms of the offer, including the merits and risks involved. You should consult your professional adviser for investment, legal, business or tax advice.
Warning
The distribution of the Replacement Prospectus outside of Australia may be restricted by law. The Replacement Prospectus is not intended to, and does not, constitute an offer of securities in any jurisdiction in which it would be unlawful to do so. New securities may not be offered or sold in any country outside Australia except to the extent permitted in the Replacement Prospectus.
The new securities may only be offered to those Eligible Shareholders with registered addresses in Australia (Eligible Country) or other investors identified and selected by Atlantic.
Atlantic has not made any investigations as to the regulatory requirements that may prevail in countries, outside of an Eligible Country in which Eligible Shareholders may reside. The distribution of this Replacement Prospectus in jurisdictions outside an Eligible Country may be restricted by law and persons who come into possession of this Replacement Prospectus should seek advice on and observe those restrictions. Any failure to comply with restrictions might constitute a violation of applicable securities laws.
It is the responsibility of any applicant outside Australia to ensure compliance with all laws of any country relevant to their application, and any such applicant should consult their professional advisers as to whether any governmental or other consents are required, or other formalities need to be observed to enable them to apply for securities pursuant to the Replacement Prospectus.
The Replacement Prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The Replacement Prospectus may not be distributed or released in the United States. The Shares referred to in the Replacement Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933 (US Securities Act) or the securities laws of any state or other jurisdiction of the United States. Accordingly, the Sale Shares may not be offered and sold, directly or indirectly, in the United States or to any person that is acting for the account or benefit of a person in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and applicable securities laws of any state or other jurisdiction of the United States.